Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia (Q58778301)

1

Tinnakorn Chaiworapongsa

0 references

Moshe Mazor

11

Moshe Mazor

0 references

Emmanuel Bujold

7

Emmanuel Bujold

0 references

Roberto Romero

2

Roberto Romero

0 references

author name string

Yeon Mee Kim

3

0 references

Gi Jin Kim

4

0 references

Mi Ran Kim

5

0 references

Jimmy Espinoza

6

0 references

Luís Gonçalves

8

0 references

Samuel Edwin

10

0 references

Ricardo Gomez

Journal of Maternal-Fetal and Neonatal Medicine

9

0 references

language of work or name

English

0 references

publication date

January 2005

0 references

published in

0 references

volume

17

0 references

issue

1

0 references

page(s)

3-18

0 references

cites work

The pathogenesis of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Etiology and pathogenesis of preeclampsia: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Recent Insights into the pathogenesis of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Diagnosis and management of gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Role of placenta in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Acute complications of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Endothelial dysfunction in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

A proposed relationship between vasopressinase altered vasopressin and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Placental cytokines and the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Expression and function of placenta growth factor: implications for abnormal placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor: possible role in fetal development and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor is increased in patients with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

The effects of angiogenic growth factors on extravillous trophoblast invasion and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

The vascular endothelium in normal pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Utero-placental vascular development and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Placenta growth factor: potential role in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Expression of vascular endothelial growth factor and placenta growth factor in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

The renal lesion of preeclampsia revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24-42 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Effect of placental resistance, arterial diameter, and blood pressure on the uterine arterial velocity waveform: a computer modeling approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Micro-bead embolization of uterine spiral arteries and changes in uterine arterial flow velocity waveforms in the pregnant ewe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Uterine flow velocity waveform shape as an indicator of maternal and placental development failure mechanisms: a model-based synthesizing approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Uterine artery Doppler velocimetry in pregnant women with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Development of the placental villous tree and its consequences for fetal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

A comparative study of fetal umbilical velocimetry with continuous- and pulsed-wave Doppler ultrasonography in high-risk pregnancies: relationship to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

VEGF(165) mediates glomerular endothelial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Oxidative stress in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Oxidative stress reproduces placental abnormalities of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816

Plasma anti-oxidant status and lipid profile in non-gravida women with a history of pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050400028816